Luvira is an orally administered prescription probiotic formulation for the clinical dietary management of suboptimal nutritional status in patients where advanced supplementation is required and nutritional supplementation in physiologically stressful conditions for maintenance of good health is needed.
The usual dose of Luvira is 3 - 4 capsules per day. The daily dose may be taken as a single dose of 3 - 4 capsules or 1 – 2 capsules twice daily with or without food.
Store at controlled room temperature 15°-30°C (59°F-86°F). Keep in cool dry place. Call your doctor about side effects. You may report side effects to FDA at 1-800-FDA-1088. KEEP THIS OUT OF THE REACH OF CHILDREN. Reserved for Professional Recommendation All prescriptions using this product shall be pursuant to state statutes as applicable. This is not an Orange Book product. This product may be administered only ...
Luvira is an orally administered prescription omega-3-acid ethyl ester dietary supplement formulation for the clinical dietary management of suboptimal nutritional status in patients where advanced supplementation is required and nutritional supplementation in physiologically stressful conditions for maintenance of good health is needed.
Luvira should be administered under the supervision of a licensed medical practitioner.
SUPPLEMENT FACTS
Serving Size: 1 Capsule
Servings Per Container:90
Amount Per Serving%Daily Value
Total Omega-3-Acid 1220mg*
Eicosapentaenoic acid (EPA) 465 mg
Docosahexaenoic acid(DHA) 375 mg
*Daily values not established
Other Ingredients: Gelatin (bovine), glycerin, de-ionized water.
Luvira is an orally administered prescription probiotic formulation for the clinical dietary management of suboptimal nutritional status in patients where advanced supplementation is required and nutritional supplementation in physiologically stressful conditions for maintenance of good health is needed.
This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.
Luvira should only be used under the direction and supervision of a licensed medical practitioner. Use with caution in patients that may have a medical condition, are pregnant, lactating, trying to conceive, under the age of 18, or taking medications.
The usual dose of Luvira is 3 - 4 capsules per day.
The daily dose may be taken as a single dose of 3 - 4 capsules or 1 – 2 capsules twice daily with or without food.
Luvira is supplied as clear yellowish Softgel capsule dispensed in white HDPE plastic bottles of 90ct.
69336-351-90
Store at controlled room temperature 15°-30°C (59°F-86°F). Keep in cool dry place. Call your doctor about side effects. You may report side effects to FDA at 1-800-FDA-1088. KEEP THIS OUT OF THE REACH OF CHILDREN.
Reserved for Professional Recommendation
All prescriptions using this product shall be pursuant to state statutes as applicable. This is not an Orange Book product. This product may be administered only under a physician’s supervision. There are no implied or explicit claims on therapeutic equivalence.
Manufactured for:
Sterling-Knight Pharmaceuticals, LLC
Ripley, MS 38663
Item 35190
Rev. 0619-1
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 69336-351-90 | EA - Each | 69336-351 | f50778a1-ea97-47f4-b1ee-e5b483a07900 | 1 | 2019-12-10 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 69336-351 | 69336-351-90 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| GELATIN | 2G86QN327L | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| OMEGA-3-ACID ETHYL ESTERS | D87YGH4Z0Q | ACTIB |
| 12-HYDROXYEICOSAPENTAENOIC ACID, (12R)- | 78P2ZC128S | ACTIB |
| 4,7,10,13,16,19-DOCOSAHEXAENOIC ACID, (4E,7E,10E,13E,16E,19E)- | ZR7NX0Z98X | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 99d7525d-b62e-7f8e-e053-2a95a90a2080 | 025679cf-dfb2-4988-9e18-2f55ef9b306f | 2019-12-16 | Warnings | 99d7525d-b62e-7f8e-e053-2a95a90a2080 025679cf-dfb2-4988-9e18-2f55ef9b306f |
Adverse event summaries are temporarily unavailable. Other product information remains available.